1. Home
  2. UHT vs LXRX Comparison

UHT vs LXRX Comparison

Compare UHT & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UHT
  • LXRX
  • Stock Information
  • Founded
  • UHT 1986
  • LXRX 1995
  • Country
  • UHT United States
  • LXRX United States
  • Employees
  • UHT N/A
  • LXRX N/A
  • Industry
  • UHT Real Estate Investment Trusts
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • UHT Real Estate
  • LXRX Health Care
  • Exchange
  • UHT Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • UHT 515.7M
  • LXRX 552.4M
  • IPO Year
  • UHT N/A
  • LXRX 2000
  • Fundamental
  • Price
  • UHT $37.30
  • LXRX $1.38
  • Analyst Decision
  • UHT
  • LXRX Buy
  • Analyst Count
  • UHT 0
  • LXRX 5
  • Target Price
  • UHT N/A
  • LXRX $3.23
  • AVG Volume (30 Days)
  • UHT 81.2K
  • LXRX 2.5M
  • Earning Date
  • UHT 10-27-2025
  • LXRX 11-06-2025
  • Dividend Yield
  • UHT 7.87%
  • LXRX N/A
  • EPS Growth
  • UHT N/A
  • LXRX N/A
  • EPS
  • UHT 1.30
  • LXRX N/A
  • Revenue
  • UHT $100,898,000.00
  • LXRX $58,432,000.00
  • Revenue This Year
  • UHT N/A
  • LXRX $66.55
  • Revenue Next Year
  • UHT $0.81
  • LXRX N/A
  • P/E Ratio
  • UHT $28.95
  • LXRX N/A
  • Revenue Growth
  • UHT 1.00
  • LXRX 1504.83
  • 52 Week Low
  • UHT $34.56
  • LXRX $0.28
  • 52 Week High
  • UHT $43.38
  • LXRX $2.08
  • Technical
  • Relative Strength Index (RSI)
  • UHT 50.93
  • LXRX 47.96
  • Support Level
  • UHT $35.69
  • LXRX $1.30
  • Resistance Level
  • UHT $37.54
  • LXRX $1.48
  • Average True Range (ATR)
  • UHT 0.86
  • LXRX 0.07
  • MACD
  • UHT 0.28
  • LXRX -0.03
  • Stochastic Oscillator
  • UHT 86.00
  • LXRX 19.65

About UHT Universal Health Realty Income Trust

Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: